Get startedLog in
    Picture of Wockhardt logo

    WOCKPHARMA — Wockhardt Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Wockhardt, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue32,30026,51027,98030,12033,730
    Cost of Revenue
    Gross Profit18,76014,75015,58017,87022,410
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses33,62029,72029,44028,32030,550
    Operating Profit-1,320-3,210-1,4601,8003,180
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-4,110-6,240-4,200-1602,380
    Provision for Income Taxes
    Net Income After Taxes-2,790-6,210-4,720-5701,990
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income-2,440-5,590-4,630-4702,130
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-2,440-5,590-4,630-4702,130
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-10.4-25.3-25.6-317.5